1. Urology surgical activity and COVID‐19: risk assessment at the epidemic peak: a Parisian multicentre experience
- Author
-
Mickael Userovici, Doriane Prost, Sabine Roux, François Desgrandchamps, Morgan Rouprêt, Gwendolyn Barker, François Audenet, R. Yiou, Olivier Cussenot, Arnaud Mejean, Steeven Bibas, Emmanuel Chartier-Kastler, Michaël Peyromaure, C. Champy, Steeve Doizi, Jacques Irani, J.-F. Hermieu, Jose Batista Da Costa, Paul Rollin, Maher Abdessater, Nicolas Couteau, Thomas Tabourin, Nouha Tobbal, Dimitri Vordos, Cedric Lebacle, Andras Hoznek, Alexandre de la Taille, Alexandre Ingels, J. Anract, and Idir Ouzaid
- Subjects
Male ,Paris ,medicine.medical_specialty ,Urology ,Pneumonia, Viral ,030232 urology & nephrology ,MEDLINE ,Severe Acute Respiratory Syndrome ,law.invention ,Research Communication ,03 medical and health sciences ,0302 clinical medicine ,law ,Humans ,Medicine ,Hospital Mortality ,Pandemics ,Academic Medical Centers ,Cross Infection ,Infection Control ,business.industry ,Incidence ,Incidence (epidemiology) ,Case-control study ,COVID-19 ,post‐operative infection ,medicine.disease ,Intensive care unit ,Intensive Care Units ,Pneumonia ,Elective Surgical Procedures ,Case-Control Studies ,030220 oncology & carcinogenesis ,Emergency medicine ,Coronavirus Disease 19 ,Urologic Surgical Procedures ,Female ,Surgery ,Observational study ,nosocomial risk ,Coronavirus Infections ,business ,Risk assessment ,Cohort study - Abstract
Objectives To evaluate the risk of contracting severe COVID‐19, defined as COVID‐19 specific intensive care unit (ICU) admission or death, for patients undergoing urological surgery during the epidemic. To define consequences of receiving surgery for COVID‐19 patients. Patients and Methods This is a multicenter observational cohort study. Every patient receiving a urological procedure in Paris academic urological centers during the 4 initial weeks of surgical restrictions were included. Their status was updated minimum 3 weeks after the procedure. The main outcomes were the COVID‐19 specific ICU admission and death. Statistics were mostly descriptive. The Post‐operative COVID‐19 confirmed group was compared with non‐COVID patients using Chi‐square tests for categorical and Wilcoxon test tests for continuous variables. Results During the 4‐week period, 552 patients received surgery within 8 centers. At follow‐up, 57 (10%) patients were lost. Among the 11 preoperative COVID‐19 cases, one remained in ICU, no new admission, and no death. For the non‐COVID patients, 57 (12%) developed COVID‐related symptoms; only one case (0.2%) required COVID‐19 specific ICU and 3 (0.6%) patients died of COVID‐19 after surgery. Conclusions Performing urological surgery during the COVID‐19 epidemic peak has a limited impact on ICU admissions but presents a real (0.6%) risk of specific mortality. Surgical activities should be maintained according to this risk.
- Published
- 2020
- Full Text
- View/download PDF